Business Description
Arch Biopartners Inc
NAICS : 325410
SIC : 3741
ISIN : CA03938C1041
Description
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | -7.87 | |||||
Debt-to-Equity | -0.7 | |||||
Debt-to-EBITDA | -1.1 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -3.6 | |||||
3-Year Book Growth Rate | 6.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.11 | |||||
9-Day RSI | 69.01 | |||||
14-Day RSI | 69.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Cash Ratio | 0.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | -1.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -919.8 | |||||
ROIC % | -95.62 | |||||
3-Year ROIIC % | -41.01 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -28.57 | |||||
EV-to-EBITDA | -28.57 | |||||
EV-to-FCF | -60.49 | |||||
Earnings Yield (Greenblatt) % | -3.5 | |||||
FCF Yield % | -1.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arch Biopartners Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.032 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 69.43 | ||
| 14-Day ATR (€) | 0.031359 | ||
| 20-Day SMA (€) | 0.3324 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.2495 - 0.586 | ||
| Shares Outstanding (Mil) | 67.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arch Biopartners Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arch Biopartners Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arch Biopartners Inc Frequently Asked Questions
What is Arch Biopartners Inc(FRA:8HA)'s stock price today?
The current price of FRA:8HA is €0.50. The 52 week high of FRA:8HA is €0.59 and 52 week low is €0.25.
When is next earnings date of Arch Biopartners Inc(FRA:8HA)?
The next earnings date of Arch Biopartners Inc(FRA:8HA) is .
Does Arch Biopartners Inc(FRA:8HA) pay dividends? If so, how much?
Arch Biopartners Inc(FRA:8HA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arch Biopartners Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers